Monday, 10th July 2006 (4593 views)

A scientist researching the use of gold nanoparticles in cancer treatment has been supported with a grant from a US cancer research body.

Steven A Curley of the University of Texas MD Anderson Cancer Centre has been awarded a grant from the American Association for Cancer Research (AACR) for his work on carbon nanotubules and gold nanoparticles as radiofrequency targets.

The association established the Jeannik M Littlefield-AACR grants in metastatic colon cancer research in February this year. Awards can be up to $250,000 and are specifically designed to help the research for new agents to treat the disease.

The grant awarded to Dr Curley highlights the growing significance of gold particles in the treatment of cancer. Another recent example is Dmitri Lapotko's research into the use of gold nanoparticles in microbubbles that could kill cancer cells, conducted at the Luikov institute in Minsk.

Dr Curley hopes to join antibodies to nanotubules and gold nanoparticles, in order to bring about homing to inoperable metastases, which can then be ablated.

He was one of 11 recipients of the award, to whom AACR spokesman David Irwin offered his "sincere congratulations".

 

« Back to the stories

 

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.